Your session is about to expire
← Back to Search
Online PLMs for Medical Education (MAP-ETT Trial)
N/A
Waitlist Available
Led By Chantal Mercier-Laporte, MD, FRCPC
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline (pre-test) and remote post-test (1 month)
Awards & highlights
MAP-ETT Trial Summary
This trial will test whether online PLMs can help medical students learn and retain the skill of estimating LVEF from TTE images.
Who is the study for?
This trial is for third or fourth-year medical students who have not had formal echocardiography training. Participants must have access to a computer with high-speed internet, as smartphones or tablets are unsuitable due to image size.Check my eligibility
What is being tested?
The study tests if online Perceptual Learning Modules (PLMs) can help medical students better estimate Left Ventricular Ejection Fraction (LVEF) from heart ultrasound images. It explores whether spaced learning through PLMs over about a month enhances this skill and its long-term retention.See study design
What are the potential side effects?
Since the intervention involves educational modules rather than medical treatments, there are no direct physical side effects expected from participating in this trial.
MAP-ETT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change between baseline (pre-test) and remote post-test (1 month)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline (pre-test) and remote post-test (1 month)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Impact of the spaced online 4 short PLMs on the ability to correctly visually estimate LVEF during a remote post-test (1 month).
Secondary outcome measures
Impact of the online perceptual modules on the ability to correctly estimate LVEF during an immediate post-test (module validation).
The fluency (time to answer) of each participant as they progress through the study protocol.
The progression (improvement of performance) of the participants' ability to correctly assess LVEF throughout the completion of the 4 modules.
MAP-ETT Trial Design
2Treatment groups
Experimental Treatment
Group I: PLM group 2Experimental Treatment1 Intervention
Participants will do a pretest (Test 2), the 4 short PLMs, an immediate post-test (Test 1) and a remote post-test (Test 2).
Group II: PLM group 1Experimental Treatment1 Intervention
Participants will do a pretest (Test 1), the 4 short PLMs, an immediate post-test (Test 2) and a remote post-test (Test 1).
Find a Location
Who is running the clinical trial?
Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
129,613 Total Patients Enrolled
Université de MontréalOTHER
214 Previous Clinical Trials
102,747 Total Patients Enrolled
Chantal Mercier-Laporte, MD, FRCPCPrincipal InvestigatorCentre hospitalier de l'Université de Montréal (CHUM)
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a third- or fourth-year medical student.
Research Study Groups:
This trial has the following groups:- Group 1: PLM group 2
- Group 2: PLM group 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any current openings for participants in this trial?
"According to clinicaltrials.gov, this particular medical trial is no longer accepting enrolment and the last update was on October 11th 2022. That being said, there are currently 9 other studies that require participants."
Answered by AI
Share this study with friends
Copy Link
Messenger